Pauline Lining Pan

Pauline Lining Pan

Auto-generated profile, based on publicly available information

Pauline Lining Pan

Life Sciences Institute, University of Michigan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2022 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
IÇIşın Çakır
Işın Çakır
CHColleen K. Hadley
Colleen K. Hadley
PPPauline Lining Pan
Pauline Lining Pan
Rushita BagchiRushita Bagchi
Rushita Bagchi
MGMasoud Ghamari-Langroudi
Masoud Ghamari-Langroudi
RCRoger D. Cone
Roger D. Cone

21 April 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
PSPatrick Sweeney
Patrick Sweeney
MBMichelle N. Bedenbaugh
Michelle N. Bedenbaugh
JMJose Maldonado
Jose Maldonado
PPPauline Pan
Pauline Pan
KFKatelyn Fowler
Katelyn Fowler
RCRoger D. Cone
Roger D. Cone
Pharmacological manipulation of the melanocortin-3 receptor bidirectionally controls feeding, providing a therapeutic target for eating disorders.

24 March 2022 in eLife
Verified
Journal Article
Open access
ICIşıN ÇaKır
IşıN ÇaKır
PPPauline Lining Pan
Pauline Lining Pan
CHColleen K Hadley
Colleen K Hadley
AEAbdulrahman El-Gamal
Abdulrahman El-Gamal
AFAmina Fadel
Amina Fadel
MGMasoud Ghamari-Langroudi
Masoud Ghamari-Langroudi
The ascending prevalence of obesity in recent decades is commonly associated with soaring morbidity and mortality rates, resulting in increased health-care costs and decreased quality of life. A systemic state of stress characterized by low-grade inflammation and pathological formation of reactive oxygen species (ROS) usually manifests in obesity. The transcription factor nuclear factor erythroid-derived 2-like 2 (NRF2) is the master regulator of the redox homeostasis and plays a critical role in the resolution of inflammation. Here, we show that the natural isothiocyanate and potent NRF2 activator sulforaphane reverses diet-induced obesity through a predominantly, but not exclusively, NRF2-dependent mechanism that requires a functional leptin receptor signaling and hyperleptinemia. Sulforaphane does not reduce the body weight or food intake of lean mice but induces an anorectic response when coadministered with exogenous leptin. Leptin-deficient Lepob/ob mice and leptin receptor mutant Leprdb/db mice display resistance to the weight-reducing effect of sulforaphane, supporting the conclusion that the antiobesity effect of sulforaphane requires functional leptin receptor signaling. Furthermore, our results suggest the skeletal muscle as the most notable site of action of sulforaphane whose peripheral NRF2 action signals to alleviate leptin resistance. Transcriptional profiling of six major metabolically relevant tissues highlights that sulforaphane suppresses fatty acid synthesis while promoting ribosome biogenesis, reducing ROS accumulation, and resolving inflammation, therefore representing a unique transcriptional program that leads to protection from obesity. Our findings argue for clinical evaluation of sulforaphane for weight loss and obesity-associated metabolic disorders.

15 October 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
YYYu Yong
Yu Yong
ICIsin Cakir
Isin Cakir
PPPauline Lining Pan
Pauline Lining Pan
JBJessica E. Biddinger
Jessica E. Biddinger
RBRebecca J. Bluett
Rebecca J. Bluett
MGMasoud Ghamari-Langroudi
Masoud Ghamari-Langroudi
Significance: Cannabis is well known to regulate food intake, and cannabinoids increase the value of caloric and non-caloric rewards, while also regulating homeostatic feeding. Here, we show that tonic endogenous cannabinoid signaling regulates the melanocortin 4 receptor (MC4R) expressing paraventricular hypothalamic neurons through modulation of their presynaptic inhibitory inputs in an energy state–dependent manner. Specifically, this tonic 2-AG signal is maximal during fasting and collapses in satiation. Impairing 2-AG synthetic capacity from MC4R neurons reduces body weight and confers resistance to diet-induced obesity via increased energy expenditure and reduced food intake. This mode of regulation of MC4R neurons could offer a new therapeutic avenue to modulate food intake and energy metabolism.